Click points to explore news by date. News sentiment ranges from -10 (very negative) to +10 (very positive) where 0 is neutral.
View Most Recent MRNA News
Assets that tend to move strongly with MRNA
Assets that tend to move strongly against MRNA
The national news cycle may have largely moved on from coverage of the COVID-19 pandemic — despite, as of this writing, infections being on the rise and more than 300 deaths tallied daily from the disease. But that certainly doesn't diminish the unprecedented international response effort and warp speed development of effective vaccines.In The Messenger: Moderna, the Vaccine, and the Business Gamble That Changed the World, veteran Wall Street Journal reporter Peter Loftus takes readers through the harrowing days of 2020 as the virus raged across the globe and biotech startup Moderna raced to create a vaccine to halt the viral rampage.
— (Engadget) (July 31) (Pocket)
Covid-19: UK will roll out Moderna's omicron BA.1 vaccine as part of autumn booster programme - The BMJ
Moderna’s bivalent covid-19 vaccine—which targets both the original version of SARS-CoV-2 and the omicron BA.1 variant—will be rolled out alongside the original Moderna, Pfizer, and Novavax covid-19 vaccines, the Joint Committee on Vaccination and Immunisation (JCVI) has said.
— (BMJ) (August 17) (Pocket)
The new vaccine is bivalent, meaning it works in a pairing. It uses a combination of the original Covid vaccine and a version that targets the currently dominant Omicron strain. Each dose contains 25 micrograms of the SARS-CoV-2 vaccine and the tailored Omicron formula, providing protection against both.
— (Weekly Standard) (August 15) (Pocket)
The U.K. is the first to approve the so-called bivalent Covid-19 booster shot, which targets the original strain of the virus as well the Omicron variant.
— (The Wall Street Journal) (August 15) (Pocket)
COVID Vaccine Injuries Quietly Being Compensated Around The World Authored by Jennifer Margulis and Joe Wang via The Epoch Times, Programs in countries around the world have begun quietly compensating people who have been injured by or died as a result of the COVID-19 vaccines. A person draws out Moderna vaccine during a drive through COVID-19 vaccine clinic at St. Lawrence College in Kingston, Ontario, on Jan. 2, 2022. (The Canadian Press/Lars Hagberg) Humans are biologically diverse, with respect to both genetic makeup and past environmental exposures. Because of this, explained neurologist Dr. Robert Lowry, people can react very differently to the same medication or vaccination.
— (ZeroHedge Opinion) (August 3) (Pocket)
2022 © Helium Trades
* Disclaimer: Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions, you should consult a financial expert before engaging in any transaction.